(1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors
The present invention relates to novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivatives as inhibitors of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compounds, to processes for preparing such compounds and compositions, and to the use of suc...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Gijsen, Henricus Jacobus Maria Buijnsters, Peter Jacobus Johannes Antonius Van Den Keybus, Frans Alfons Maria Tresadern, Gary John Van Roosbroeck, Yves Emiel Maria Velter, Adriana Ingrid |
| description | The present invention relates to novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivatives as inhibitors of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2017353313BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2017353313BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2017353313BB23</originalsourceid><addsrcrecordid>eNrjZLDVMNQx0jHRLCnKTKzKz8kHck11EzULKosyczNTMvNSFZLzcwvyS_NSihUSixUCXFyNFDLzMjKTMkvyi4p5GFjTEnOKU3mhNDeDiptriLOHbmpBfnxqcUFicmpeakm8Y6iRgaG5samxsaGxk5ORMZHKAAc4L0c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>(1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors</title><source>esp@cenet</source><creator>Gijsen, Henricus Jacobus Maria ; Buijnsters, Peter Jacobus Johannes Antonius ; Van Den Keybus, Frans Alfons Maria ; Tresadern, Gary John ; Van Roosbroeck, Yves Emiel Maria ; Velter, Adriana Ingrid</creator><creatorcontrib>Gijsen, Henricus Jacobus Maria ; Buijnsters, Peter Jacobus Johannes Antonius ; Van Den Keybus, Frans Alfons Maria ; Tresadern, Gary John ; Van Roosbroeck, Yves Emiel Maria ; Velter, Adriana Ingrid</creatorcontrib><description>The present invention relates to novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivatives as inhibitors of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210916&DB=EPODOC&CC=AU&NR=2017353313B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210916&DB=EPODOC&CC=AU&NR=2017353313B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gijsen, Henricus Jacobus Maria</creatorcontrib><creatorcontrib>Buijnsters, Peter Jacobus Johannes Antonius</creatorcontrib><creatorcontrib>Van Den Keybus, Frans Alfons Maria</creatorcontrib><creatorcontrib>Tresadern, Gary John</creatorcontrib><creatorcontrib>Van Roosbroeck, Yves Emiel Maria</creatorcontrib><creatorcontrib>Velter, Adriana Ingrid</creatorcontrib><title>(1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors</title><description>The present invention relates to novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivatives as inhibitors of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDVMNQx0jHRLCnKTKzKz8kHck11EzULKosyczNTMvNSFZLzcwvyS_NSihUSixUCXFyNFDLzMjKTMkvyi4p5GFjTEnOKU3mhNDeDiptriLOHbmpBfnxqcUFicmpeakm8Y6iRgaG5samxsaGxk5ORMZHKAAc4L0c</recordid><startdate>20210916</startdate><enddate>20210916</enddate><creator>Gijsen, Henricus Jacobus Maria</creator><creator>Buijnsters, Peter Jacobus Johannes Antonius</creator><creator>Van Den Keybus, Frans Alfons Maria</creator><creator>Tresadern, Gary John</creator><creator>Van Roosbroeck, Yves Emiel Maria</creator><creator>Velter, Adriana Ingrid</creator><scope>EVB</scope></search><sort><creationdate>20210916</creationdate><title>(1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors</title><author>Gijsen, Henricus Jacobus Maria ; Buijnsters, Peter Jacobus Johannes Antonius ; Van Den Keybus, Frans Alfons Maria ; Tresadern, Gary John ; Van Roosbroeck, Yves Emiel Maria ; Velter, Adriana Ingrid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2017353313BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Gijsen, Henricus Jacobus Maria</creatorcontrib><creatorcontrib>Buijnsters, Peter Jacobus Johannes Antonius</creatorcontrib><creatorcontrib>Van Den Keybus, Frans Alfons Maria</creatorcontrib><creatorcontrib>Tresadern, Gary John</creatorcontrib><creatorcontrib>Van Roosbroeck, Yves Emiel Maria</creatorcontrib><creatorcontrib>Velter, Adriana Ingrid</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gijsen, Henricus Jacobus Maria</au><au>Buijnsters, Peter Jacobus Johannes Antonius</au><au>Van Den Keybus, Frans Alfons Maria</au><au>Tresadern, Gary John</au><au>Van Roosbroeck, Yves Emiel Maria</au><au>Velter, Adriana Ingrid</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>(1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors</title><date>2021-09-16</date><risdate>2021</risdate><abstract>The present invention relates to novel [1,2,4]triazolo[1,5-a]pyrimidin-yl derivatives as inhibitors of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2017353313BB2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | (1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T19%3A52%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Gijsen,%20Henricus%20Jacobus%20Maria&rft.date=2021-09-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2017353313BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |